ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (120 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bmcl.2006.01.072    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2006 Elsevier Ltd All rights reserved.

Synthesis and antibacterial activities of chiral 1,3-oxazinan-2-one derivatives

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Guijun WangCorresponding Author Contact Information, E-mail The Corresponding Author, Jean-Rene Ella-Menye and Vibha Sharma

Department of Chemistry, University of New Orleans, LA 70148, USA


Received 1 December 2005; 
revised 11 January 2006; 
accepted 12 January 2006. 
Available online 21 February 2006.

Abstract

We report here the design, synthesis, and antibacterial activities of novel classes of compounds containing chiral 1,3-oxazinan-2-ones and oxazolidinones as the basic core structures. These compounds are tertiary amines containing the core structures and two aryl substituents. Several of these molecules exhibit potent antibacterial activities against the tested Gram-positive bacteria, including Staphylococcus aureus, Enterococcus faecalis, and Bacillus subtilis. These compounds represent new structure scaffolds and can be further optimized to give new antibacterial agents with structures significantly different from those of existing classes of antibiotics.

Graphical abstract

The compounds exhibit interesting antibacterial activities toward Gram-positive bacteria. The oxazinan-2-one is a new chiral heterocycle for potentially new class of antimicrobials.


Keywords: Oxazinanone; Oxazolidinone; Antibacterial agents; Synthesis

Article Outline

Acknowledgements
Supplementary material
References







Corresponding Author Contact InformationCorresponding author. Tel.: +1 504 280 1258; fax: +1 504 280 6860.

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.